바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.78 No.1
Citation Share

Thrombotic Complications during Interventional Lung Assist: Case Series

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2015, v.78 no.1, pp.18-22









& (2015). Thrombotic Complications during Interventional Lung Assist: Case Series. Tuberculosis & Respiratory Diseases, 78(1), 18-22.
  • Downloaded
  • Viewed
PDF Download

Abstract

Interventional lung assist (iLA) effectively reduces CO2 retention and allowsprotective ventilation in cases of life-threatening hypercapnia. Despite the clinicalefficacy of iLA, there are a few major limitations associated with the use of thisapproach, such as bleeding, thrombosis, and catheter-related limb ischemia. We presented two cases in which thrombotic complications developed during iLA. We demonstrated the two possible causes of thrombotic complications during iLA;stasis due to low blood flow and inadequate anticoagulation.

keywords
Lung, Complications, Thrombosis

Reference

1.

1. Tao W., Brunston RL Jr., Bidani A., Pirtle P., Dy J., Cardenas VJ Jr. (1997), Significant reduction in minute ventilation and peak inspiratory pressures with arteriovenous CO2 removal during severe respiratory failure. Crit Care Med, 25,689-95.

2.

2. Liebold A., Reng CM., Philipp A., Pfeifer M., Birnbaum DE. (2000), Pumpless extracorporeal lung assist: experience with the first 20 cases. Eur J Cardiothorac Surg, 17,608-13.

3.

3. Bein T., Weber F., Philipp A., Prasser C., Pfeifer M., Schmid FX. (2006), A new pumpless extracorporeal interventional lung assist in critical hypoxemia/hypercapnia. Crit Care Med, 34,1372-7.

4.

4. Zick G., Frerichs I., Schadler D., Schmitz G., Pulletz S., Cavus E. (2006), Oxygenation effect of interventional lung assist in a lavage model of acute lung injury: a prospective experimental study. Crit Care, 10,R56.

5.

5. Zimmermann M., Bein T., Arlt M., Philipp A., Rupprecht L., Mueller T. (2009), Pumpless extracorporeal interventional lung assist in patients with acute respiratory distress syndrome: a prospective pilot study. Crit Care, 13,R10.

6.

6. Jayroe JB., Wang D., Deyo DJ., Alpard SK., Bidani A., Zwischenberger JB. (2003), The effect of augmented hemodynamics on blood flow during arteriovenous carbon dioxide removal. ASAIO J, 49,30-4.

7.

7. Cho WH., Lee K., Huh JW., Lim CM., Koh Y., Hong SB. (2012), Physiologic effect and safety of the pumpless extracorporeal interventional lung assist system in patients with acute respiratory failure: a pilot study. Artif Organs, 36,434-8.

8.

8. Bein T., Zimmermann M., Philipp A., Ramming M., Sinner B., Schmid C. (2011), Addition of acetylsalicylic acid to heparin for anticoagulation management during pumpless extracorporeal lung assist. ASAIO J, 57,164-8.

9.

9. Villaneuva GB., Danishefsky I. (1977), Evidence for a heparin-induced conformational change on antithrombin III. Biochem Biophys Res Commun, 74,803-9.

10.

10. Oliver WC. (2009), Anticoagulation and coagulation management for ECMO. Semin Cardiothorac Vasc Anesth, 13,154-75.

Tuberculosis & Respiratory Diseases

e-Submission OA Policy